⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1025985 | 1.00 | — | — | |
| SCHEMBL3575500 | 0.71 | — | — | |
| SCHEMBL3575503 | 0.71 | — | — | |
| SCHEMBL6977352 | 0.69 | — | — | |
| SCHEMBL944868 | 0.67 | — | — | |
| SCHEMBL1809769 | 0.67 | — | — | |
| SCHEMBL27873199 | 0.67 | — | — | |
| SCHEMBL14061003 | 0.67 | — | — | |
| SCHEMBL4194764 | 0.67 | — | — | |
| SCHEMBL151293 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9688906-B2 | Boronated biopolymer crosslinking agents and methods relating thereto | HALLIBURTON ENERGY SERVICS, INC. (US) | 2017-06-27 | — | — | US | claimed |
| US-9340575-B2 | Agonists and antagonists of the urotensinergic system | INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2016-05-17 | — | — | US | claimed |
| US-20150075789-A1 | Boronated Biopolymer Crosslinking Agents and Methods Relating Thereto | HALLIBURTON ENERGY SERVICES, INC. (US) | 2015-03-19 | — | — | US | claimed |
| WO-2015002669-A1 | BORONATED BIOPOLYMER CROSSLINKING AGENTS AND METHODS RELATING THERETO | HALLIBURTON ENERGY SERVICES, INC. (US) | 2015-01-08 | — | — | WO | claimed |
| EP-2729184-A1 | NOVEL AGONISTS AND ANTAGONISTS OF THE UROTENSINERGIC SYSTEM | Institut National de la Recherche Scientifique (CA) | 2014-05-14 | — | — | EP | claimed |
| US-20140113872-A1 | NOVEL AGONISTS AND ANTAGONISTS OF THE UROTENSINERGIC SYSTEM | INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2014-04-24 | — | — | US | claimed |
| US-8361484-B2 | Polymer systems for lung volume reduction therapy | AERIS THERAPEUTICS, INC. (US) | 2013-01-29 | — | — | US | claimed |
| WO-2012149644-A1 | NOVEL AGONISTS AND ANTAGONISTS OF THE UROTENSINERGIC SYSTEM | INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2012-11-08 | — | — | WO | claimed |
| US-20100040538-A1 | Polymer Systems for Lung Volume Reduction Therapy | CANADIAN IMPERIAL BANK OF COMMERCE (CA) | 2010-02-18 | — | — | US | claimed |
| EP-2059227-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | Aeris Therapeutics, Inc. (US) | 2009-05-20 | — | — | EP | claimed |
| WO-2008039827-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | AERIS THERAPEUTICS, INC. (US) | 2008-04-03 | — | — | WO | claimed |
| US-12428419-B2 | Therapeutic compounds | GENENTECH, INC. (US) | 2025-09-30 | — | — | US | disclosed |
| US-20240383897-A1 | THERAPEUTIC COMPOUNDS | GENENTECH, INC. (US) | 2024-11-21 | — | — | US | disclosed |
| EP-4384517-A1 | PHENOL DERIVATIVES FOR USE IN THE MODULATION OF BRM | Genentech, Inc. (US) | 2024-06-19 | — | — | EP | disclosed |
| US-11993599-B2 | Therapeutic compounds | GENENTECH, INC. (US) | 2024-05-28 | — | — | US | disclosed |
| WO-2008039827-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | AERIS THERAPEUTICS, INC. (US) | 2008-04-03 | — | — | WO | disclosed |
| US-20070082880-A1 | Thieno [2,3-B] pyridine-5-carbonitriles as protein kinase inhibitors | WYETH | 2007-04-12 | — | — | US | disclosed |
| WO-2007038519-A1 | THIENO[2,3-B]PYRIDINE-5-CARBONITRILES AS PROTEIN KINASE INHIBITORS | WYETH (US) | 2007-04-05 | — | — | WO | disclosed |
| US-20060224011-A1 | Catalyst composition and process for producing cross-coupled compound using same | TOSOH CORPORATION | 2006-10-05 | — | — | US | disclosed |
| EP-1707263-A1 | Catalyst composition comprising an alkylene diamine-nickel complex and process for producing a cross-coupled compound using the same | Tosoh Corporation (JP) | 2006-10-04 | — | — | EP | disclosed |